Human Insulin Degrading Enzyme (IDE) ELISA Kit (Part hIDE-Biotin) kw: insulin degrading enzyme, insulysin

Human Insulin Degrading Enzyme (IDE) ELISA Kit (Part hIDE-Biotin) kw:  insulin degrading enzyme, insulysin
Click to enlarge
Price: $625.00
Availability: In Stock
Model: hIDE-Biotin (96T)

Available Options:

Human Insulin Degrading Enzyme (IDE) ELISA Kit

Dynamic Assay Range:  600 pg/ml - 180 ng/ml.  Sensitivity: 544 pg/ml.  96T 
Lead Time:  Approximately 1.5 weeks

Specifications
  • Fully pre-configured ELISA kit in sandwich assay format.
  • Strip plate configuration allowing separated assays:  96T
  • Dynamic Assay Range: 600 pg/ml - 180 ng/ml for human.  Sensitivity: 544 pg//ml.
  • Rapid ELISA Protocol:  Requires one 60 min incubation period at 37oC.
  • Samples are mixed by the experimenter with the provided biotinylated detection antibody and a provided streptavidin-HRP solution prior to the addition of the mixture to the ELISA plate.
  • Available in 96T formats.


Number of Assays
Cost
96T
$625
2 x 96T
$1170


Methods Overview:
The included ELISA micro-strip plate is provided pre-coated with an a monoclonal capture antibody selective to the antigen.  Samples are mixed by the experimenter with a provided biotin-linked detection antibody and a streptavidin-HRP solution, and then the mixture is added to the plate for 60 min at 37oC. The plate is washed after the 60 min incubation period and color reagents are added, resulting in a reaction that yields a blue colored solution.  A stop solution is applied to terminate the reaction, and the resulting yellow solution is measured at 450nm.

   Protocol


   Sandwich ELISA Methods to Insulin Degrading Enzyme (IDE)                                                       

ELISA Assay Steps
  1. Mix samples with the provided biotinylated-detection antibody and streptavidin-HRP solutions.
  2. Apply mixture to ELISA plate for 60min at 37oC.  Then wash 5 times.
  3. Apply and incubate with chromogens, stop the reaction and measure at 450nm.


Introduction to Insulin Degrading Enzyme:   
Insulin-degrading enzyme (IDE) is a zinc-binding protease known to cleave short polypeptides with variable sequences.  IDE was first identifiable for its ability to degrade the B chain of insulin and has since been shown to have additional substrates, including the signaling peptides glucagon, TGF alpha, β-endorphin and amyloid-beta (Aβ). In vitro and in vivo studies have shown correlations between IDE activity levels, Aβ degradation, and Alzheimer’s disease.  Mice engineered to lack both alleles of the IDE gene show a 50% decrease in Aβ degradation, resulting in cerebral accumulation of Aβ.  Studies of genetically inherited forms of Alzheimer’s show reduction in both IDE expression and catalytic activity among affected individuals.

Gerneral References on Insulin Degrading Enzyme
  1. Amata, O., Marino, T., Russo, N., & Toscano, M. (2009). Human insulin-degrading enzyme working mechanism. Journal of the American Chemical Society131(41), 14804-14811.
  2. Bennett, R. G., Duckworth, W. C., & Hamel, F. G. (2000). Degradation of amylin by insulin-degrading enzyme. The Journal of Biological Chemistry275(47), 36621-36625.
  3. Grasso, G., Rizzarelli, E., & Spoto, G. (2008). How the binding and degrading capabilities of insulin degrading enzyme are affected by ubiquitin. Biochimica et Biophysica Acta1784(7-8), 1122-1126.
  4. Hong, M.-G., Reynolds, C., Gatz, M., Johansson, B., Palmer, J. C., Gu, H. F., Blennow, K., et al. (2008). Evidence that the gene encoding insulin degrading enzyme influences human lifespan. Human Molecular Genetics17(15), 2370-2378. Oxford University Press.
  5. Im, H., Manolopoulou, M., Malito, E., Shen, Y., Zhao, J., Neant-Fery, M., Sun, C.-Y., et al. (2007). Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. The Journal of Biological Chemistry,282(35), 25453-25463.
  6. Vepsalainen, S., Hiltunen, M., Helisalmi, S., Wang, J., Van Groen, T., Tanila, H., & Soininen, H. (2008). Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer’s disease-like neuropathology. Neuroscience Letters

For research only.  Not for diagnostics.
Safety:  Stop solution contains acid.   Avoid ingestion, skin and eye contact.
Storage:  4°C. 6 months.


 

Category Download Link
Protocol Manual click here
MSDS click here